10 ML oxaliplatin 5 MG/ML Injection

Known as: OXALIPLATIN 50 mg in 10 mL INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE, OXALIPLATIN 5 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE_#1, OXALIPLATIN 50MG/VIL (PF) INJ [VA Product] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2016
02420002016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
To compare the outcomes of two neoadjuvant radiochemotherapy (N-RCT) regimens for squamous cell carcinoma of the esophagus (ESCC… (More)
  • table 1
  • figure 1 9
  • table 3
  • table 2
  • table 4
Is this relevant?
Review
2014
Review
2014
Die perioperative Radiochemotherapie (RChT) beim lokal fortgeschrittenen Rektumkarzinom (LARC) ist seit den 1990er Jahren als… (More)
Is this relevant?
Review
2010
Review
2010
Die heutige Behandlung kolorektaler Karzinome erfordert die intensive Zusammenarbeit von Chirurgen, Strahlentherapeuten und… (More)
Is this relevant?
Review
2010
Review
2010
CONTEXT Pancreatic cancer is noteworthy in that the number of patients dying from the disease is roughly equal to the number… (More)
Is this relevant?
2008
2008
Some DNA damage-recognition proteins, transcription factors, mismatch repair proteins and DNA polymerases discriminate between… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Das Platinderivat Oxaliplatin wird bei der Chemotherapie des kolorektalen Karzinoms eingesetzt. Sein Nebenwirkungsprofil… (More)
Is this relevant?
2004
2004
Eine adjuvante Radiochemotherapie verbessert im Stadium II (T3–4N0) und III (TxN1–2) das Überleben und senkt die Rate an… (More)
Is this relevant?
2001
2001
Hintergrund: Die Therapiemöglichkeiten des fortgeschrittenen kolorektalen Karzinoms haben sich in den letzten Jahren erheblich… (More)
Is this relevant?
2000
2000
DNA polymerase beta (pol beta) is the only mammalian DNA polymerase identified to date that can catalyze extensive bypass of… (More)
Is this relevant?